U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT06872541) titled 'Evaluation of Platelet Aggregability in Patients with Non-small Cell Lung Carcinomas' on March 06.
Brief Summary: Cancer patients are at greater risk of experiencing events thrombotic, arterial or venous, during the course of the disease. Specifically in lung cancer, patients are seven times more prone to developing venous thrombosis, when compared to general population. Platelets influence cancer progression and Tumor microenvironment facilitates platelet activation. Therefore, the main objective of this project is to evaluate platelet aggregation analyzed by aggregometry optics with the use of AggRAM(R) equipment in patients diag...